Pyridostigmine Bromide
- Product NDC
- 42192-626
- 11-digit product format
- 421920626
- Labeler code
- 42192
- Product ID
- 42192-626_40422b8d-3f5d-6590-e063-6394a90a1532
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pyridostigmine bromide
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Acella Pharmaceuticals, LLC
- Application
- ANDA212405
- Marketing category
- ANDA
- Marketing start
- 2023-10-09
- Substance
- PYRIDOSTIGMINE BROMIDE
- Active strength
- 60 mg/5mL
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pyridostigmine Bromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PYRIDOSTIGMINE BROMIDE | 60 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | KVI301NA53 |
| Rxcui | 903843 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42192-626-16 | Pyridostigmine Bromide | 473 mL in 1 BOTTLE | SOLUTION | 473 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42192-626 | PYRIDOSTIGMINE BROMIDE SOLUTION [ACELLA PHARMACEUTICALS, LLC] | 2 | Current NDC, 1 package rows | 20241011_56999559-274e-44ea-a317-29366fdca908.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 42192-626-16 | 42192062616 | 473 mL in 1 BOTTLE (42192-626-16) | 473 ml | 2023-10-09 | No | No | Current |